Fig 1: SNF2H organizes nucleosomes at CTCF binding sites.(A-C) Mono nucleosomes were isolated from cell lines following siRNA depletion of proteins indicated. Sequencing of the nucleosomal DNA enabled reads to be mapped with respect to CTCF sites. The strong nucleosome organization flanking the CTCF binding sites is disrupted following depletion of either CTCF (A) or SNF2H (B). The depletion of SNF2L (C) shows only a small effect. The same control depletion data is plotted in (B) and (C).
Fig 2: Assessment of DNA damage in siSMARCA5, siINO80, and siMTA2 cells.a Percentage of cells with >5 γH2AX foci in control (siC) and SMARCA5, INO80, MTA2-depleted cells that overexpress (+) or not (−) RNH1. Data expressed as relative to siC. Mean + SEM are plotted (n = 4 (siSMARCA5 and siINO80) and n = 6 (siC and siMTA2) independent experiments). (Unpaired Student’s t test, one-tailed). b Quantification of nuclear S9.6 mean signal intensity in siSMARCA5 and siINO80 cells treated as in (a). Data presented as scatter plot (n > 100 cells examined over 3 independent experiments). Median values are indicated. (Mann–Whitney U-test, two-tailed). c DRIP-qPCR analysis of RNAPII (RPL13A, FOXP4, TAF9B) and RNAPI-transcribed genes (5’ and 28S rDNA) of siC, siSMARCA5 (left) and siINO80 (right) cells. Signal values normalized with respect to the siC control and plotted as mean ± SEM (n = 5 (RPL13A, FOXP4 and 5’ rDNA) and n = 4 (TAF9B and 28S rDNA) independent experiments). (Unpaired Student’s t test, one-tailed). Representative images, with nuclear perimeter highlighted (yellow dashed line), are shown. Gene regions amplified by qPCR in DRIP-qPCR experiments are indicated with a red line on drawings of the genes tested. Scale bars and p values are indicated. Source data are provided as a Source data file. See also Supplementary Fig. 3.
Fig 3: Generation of GNP cultures from the Ex6DEL mice. (A) Schematic diagram of the procedure for generating GNP and granule neuron cultures. (B) Representative images of WT cultures 1 DIV (top image) and 3 DIV (bottom image) stained with neurofilament-200 (red). Scale bar, 25 μM. (C) Protein extracts of primary GNP cultures at I and 3 DIV were immunoblotted for the ISWI proteins (Snf2h, Snf2l), neuronal (Tuj, NeuN) and proliferation (Ki67) markers. Vinculin was used as a loading control. (D) Immunoblot (top panel), Smarca1 genotyping (middle panel), and RNAseq analysis (bottom panel) from WT and Ex6DEL GNP cultures confirmed the loss of exon 6 in the GNP cultures isolated from Ex6DEL mice. The red rectangle outlines the absence of RNAseq reads corresponding to the position of exon 6. (E) Phase contrast images of GNP cultures from WT and Ex6DEL mice. Scale bar, 50 μM.
Fig 4: SNF2L and SNF2H contribute to the nucleosome phasing at transcription factor binding sites.(A-D) Nucleosome density plots of sequenced mono nucleosomal DNA after depletion of SNF2L and SNF2H proteins mapped to the JUN (A, B) or RFX5 (C, D) transcription factor binding sites. Depleting SNF2L (A, C green) shows an effect on the factor proximal nucleosomes at majority of transcription factor binding sites while the effect of SNF2H knock down (B, D blue) affects distal nucleosomes at the binding sites for factors such as JUN (see main text). Transcription factors such as E2H2 (E, F) and GTF3C2 (G, H) that have no well organised nucleosomes are less affected by the depletion of SNF2H (F, H blue) or SNF2L (E, G green). In all plots data was only taken from factor binding sites that do not have adjacent CTCF sites.
Fig 5: Normal and aberrant NURF subunit switching during mouse cortical development.A) The NURF complex is expressed in proliferating neuroprogenitors (NPCs) and in differentiated neurons during murine corticogenesis. B) During normal cortical development (WT) the catalytic subunit within NURF during growth is SNF2H (encoded by SMARCA5). During differentiation, the catalytic subunit is switched to SNF2L (encoded by SMARCA1). C) Ablation of the Bptf gene (Bptf cKO) prevents formation of the NURF complex and results in minimal growth and a severely hypoplastic cortex. Individuals with BPTF pathogenic variants also present with microcephaly. D) When Smarca5 is inactivated (Smarca5 cKO), there is some compensation by SNF2L during growth that results in a smaller cortex but one that is slightly larger than the Bptf cKO mice. Individuals with SMARCA5 variants also present with microcephaly. E) Smarca1 knockout mice (Smarca1cKO) have a normal sized cortex which results from near complete compensation by the SNF2H protein. Individuals with SMARCA1 nonsense LOF variants have a high penetrance of macrocephaly, which is discordant from the mouse phenotype. F) In the Ex6DEL mice subunit switching occurs normally but the mutant protein lacks remodeling activity creating a dominant negative effect that delays differentiation and results in a larger brain size. Individuals with SMARCA1 variants and macrocephaly are predicted to lack remodeling activity and function in a dominant negative fashion while other missense variants that don’t abolish remodeling activity are not macrocephalic.
Supplier Page from Abcam for Anti-SNF2H antibody